Remacemide
Remacemide is a pharmacological agent that was initially developed for the treatment of epilepsy. It is a low-affinity, non-competitive NMDA receptor antagonist. Remacemide and its major metabolite, FPL 12495AA, have been shown to have neuroprotective effects in animal models of neurodegenerative diseases such as Parkinson's disease and Huntington's disease. However, clinical trials in humans have not shown significant benefits, and development of the drug has been discontinued.
Pharmacology[edit | edit source]
Remacemide acts as a non-competitive antagonist at the NMDA receptor, a type of ionotropic glutamate receptor. It has a low affinity for the receptor, which means it does not bind strongly and can be easily displaced. This is in contrast to high-affinity NMDA receptor antagonists, which bind tightly and are not easily displaced.
Remacemide's major metabolite, FPL 12495AA, also acts as a non-competitive NMDA receptor antagonist. Both remacemide and FPL 12495AA have been shown to have neuroprotective effects in animal models of neurodegenerative diseases.
Clinical trials[edit | edit source]
Remacemide has been tested in clinical trials for several conditions, including epilepsy, Parkinson's disease, and Huntington's disease. However, these trials have not shown significant benefits.
In trials for epilepsy, remacemide was found to be less effective than other available treatments. In trials for Parkinson's disease and Huntington's disease, remacemide did not show significant benefits over placebo.
As a result of these findings, development of remacemide has been discontinued.
See also[edit | edit source]
- NMDA receptor antagonist
- Neurodegenerative diseases
- Epilepsy
- Parkinson's disease
- Huntington's disease
Remacemide Resources | ||
---|---|---|
|
|
|
Find a healthcare provider anywhere in the world quickly and easily!
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
WikiMD is the world's largest, free medical and wellness encyclopedia edited only by professionals. Advertise!
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD